Surviving Is Not the End of the Story: Inside the Childhood Cancer Survivor Study
19 minutes ago
1 min read
But five-year survival answers only one question: whether a child lived through the immediate threat of cancer. It says much less about what happens at 25, 40, or 60—decades after the last dose of chemotherapy, a biologic, or the final radiation treatment. That question, largely invisible in headline survival statistics, is the subject of one of the longest-running and most influential research efforts in childhood cancer: the Childhood Cancer Survivor Study (CCSS).

